Sjögren’s Syndrome News

The COVID-19 pandemic brought with it a significant decrease in autoimmunity laboratory testing, first rheumatology visits and diagnoses from 2019 to 2020, according to Italian data published in The Journal of Rheumatology.

Despite a significant decrease in anxiety related to COVID-19, patients with autoimmune rheumatic disease continue to experience frequent interruptions in their medication use, according to survey data presented at ACR Convergence 2021.

Hour-long, virtual exercise classes that cover Pilates, yoga and tai chi are safe and improved health outcomes in patients with musculoskeletal disease, according to data presented at ACR Convergence 2021.

Managing oral, ocular and cutaneous complications is critical to optimizing outcomes in conditions ranging from Sjögren’s syndrome to juvenile dermatomyositis, according to a presenter who offered a cross-section of “pearls and myths” at ACR Convergence 2021.

Heart rate monitoring may be a crucial means of detecting rhythm abnormalities in the fetuses of pregnant individuals who are positive for anti-Ro/SSA antibodies, according to data presented at ACR Convergence 2021.

Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.

It is likely that one or more “promising treatments” currently being investigated for Sjögren’s syndrome will come into use within the next 3 to 5 years, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

Although immunosuppressives remain the cornerstone for managing underlying interstitial lung disease in connective tissue diseases, new drug approvals could help shift the treatment paradigm, according to data presented here.

Cancer screening recommendations for patients with autoimmune diseases largely rely on clinical experience and extrapolation in the absence of abundant data, according to a speaker at the 2021 Congress of Clinical Rheumatology-East meeting.

While the 2021 consensus guidelines for pulmonary disease in Sjögren’s syndrome may have shed light on this underdiagnosed complication, gaps remain in identification and management of the disease, noted a presenter here.